ROCHE's PURCHASE OF SYNTEX WILL NOT AFFECT ALEVE
This article was originally published in The Tan Sheet
Executive Summary
ROCHE's PURCHASE OF SYNTEX WILL NOT AFFECT ALEVE, P&G said in response to the announcement that Hoffmann-La Roche has signed an agreement to acquire Syntex. A Procter & Gamble spokesperson said the company plans to begin shipping the new naproxen sodium-based OTC analgesic "over the next few weeks" under a development and marketing joint venture arrangement with Syntex. The P&G/Syntex joint venture also markets the analgesic Percogesic and has options to develop future Rx-to-OTC switches.